Sponsor Pipeline

Criterium, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
1
Recruiting
3
Disease Areas
Active Trials by Phase
Phase 2
3
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06992258 A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in… Colorectal Cancer Recruiting
NCT04567420 DNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor… Breast Cancer Active, Not Recruiting
NCT05458674 Tucatinib+Trastuzumab+Eribulin in HER2+ MBC Breast Cancer Active, Not Recruiting
Phase 1/2
NCT05230810 Clinical Trial of Alpelisb and Tucatinib in Patients With PIK3CA-Mutant HER2+ Metastatic… HER2-positive Metastatic Breast Cancer Active, Not Recruiting
Disease Areas
Breast Cancer (3) HER2-Positive Breast Cancer (1) Colorectal Cancer (1)
Get alerts when Criterium, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free